HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bayer Extra Strength Parity Claims With Rx Tylenol Upheld By NAD

This article was originally published in The Tan Sheet

Executive Summary

An Extra Strength Bayer Aspirin Gelcaps ad claim stating it provides pain relief equivalent to prescription Tylenol with Codeine #3 is supported by scientific evidence, the National Advertising Division of the Council of Better Business Bureaus concludes in the May NAD Case Reports.

You may also be interested in...

Bayer Pulls Aleve Ads Touting Parity With Rx Drugs At NAD’s Request

Bayer will stop airing radio and TV ads for Aleve with the statement, "Prescription-strength relief without a prescription," following a recent National Advertising Division inquiry

Bayer Aspirin, Rx Tylenol With Codeine #3 Equally Efficacious - Study

Extra Strength Bayer Aspirin is as effective as Rx Tylenol with Codeine #3, Bayer researchers conclude in a study presented at the American Pain Society annual scientific meeting in Phoenix April 21.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts